Listen as Board Certified Orthopedic Surgeon, Dr. Wade McKenna discusses how minimally-invasive arthroscopic surgery plus stem cells in combination with amniotic membrane are being used to heal a torn meniscus. The video, below, is followed by key points regarding this recently developed treatment.
Key Points Include:
- Bone marrow-derived stem cells with the inclusion of amniotic membrane are being used to treat a torn meniscus, a common injury resulting from over-twisting tissue within the knee
- Arthroscopy followed by stem cell injection restores the cartilaginous surface within the knee joint and creates a healthy environment for healing by removing matrix metalloproteinases, degrading enzymes that are secreted when walking with a torn meniscus
- One of the amazing benefits of this treatment, in addition to its healing aspect, is its ability to prevent further tearing of the meniscus!
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.